Inhibrx Biosciences (INBX) Q4 2022 Earnings

6MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.97
-0.85
-0.72
-0.6

Details

Expected EPS
-0.79
Actual EPS
-0.95
Surprise EPS
-0.16
Surprise Percent
+20.25%

Description

Inhibrx Biosciences (INBX) has reported earnings of -0.95 per share for Q4 2022.

0 Comments

Share your thoughts